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Abstract
The effects of disease mutations on protein structure and function have been extensively investigated, and many predictors
of the functional impact of single amino acid substitutions are publicly available. The majority of these predictors are based
on protein structure and evolutionary conservation, following the assumption that disease mutations predominantly affect
folded and conserved protein regions. However, the prevalence of the intrinsically disordered proteins (IDPs) and regions
(IDRs) in the human proteome together with their lack of fixed structure and low sequence conservation raise a question
about the impact of disease mutations in IDRs. Here, we investigate annotated missense disease mutations and show that
21.7% of them are located within such intrinsically disordered regions. We further demonstrate that 20% of disease
mutations in IDRs cause local disorder-to-order transitions, which represents a 1.7–2.7 fold increase compared to annotated
polymorphisms and neutral evolutionary substitutions, respectively. Secondary structure predictions show elevated rates of
transition from helices and strands into loops and vice versa in the disease mutations dataset. Disease disorder-to-order
mutations also influence predicted molecular recognition features (MoRFs) more often than the control mutations. The
repertoire of disorder-to-order transition mutations is limited, with five most frequent mutations (RRW, RRC, ERK, RRH,
RRQ) collectively accounting for 44% of all deleterious disorder-to-order transitions. As a proof of concept, we performed
accelerated molecular dynamics simulations on a deleterious disorder-to-order transition mutation of tumor protein p63
and, in agreement with our predictions, observed an increased a-helical propensity of the region harboring the mutation.
Our findings highlight the importance of mutations in IDRs and refine the traditional structure-centric view of disease
mutations. The results of this study offer a new perspective on the role of mutations in disease, with implications for
improving predictors of the functional impact of missense mutations.
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Introduction
Recent years have seen significant advancements in cataloging
the genetic variation in humans and relating it to disease
susceptibility. In particular, missense mutations, which introduce
changes in the amino acid sequence of proteins, have been the
subject of considerable attention due to the large number of
ongoing exome sequencing studies. As a result, numerous
computational models that classify amino acid substitutions as
damaging or benign are currently available (reviewed in [1,2,3]).
The majority of these methods rely on the information from solved
or modeled protein structures [4,5,6,7,8,9] and/or are based on
evolutionary conservation, following the assumption that func-
tionally important residues of proteins are conserved
[10,11,12,13]. This choice of features limits the usefulness of
current methods for classifying mutations in proteins that lack a
fixed structure or have low sequence conservation, both of which
are hallmarks of the intrinsically disordered proteins (IDPs).
Underestimating the impact of missense mutations in intrinsically
disordered regions (IDRs) leads to a decrease in overall sensitivity
of the existing methods. For example, it has recently been
observed that SIFT predictions have more false negatives on
annotated disease mutations in disordered, solvent accessible and
non-conserved regions [14].
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Intrinsically disordered proteins were first identified as a distinct
class of proteins more than a decade ago [15,16,17,18]. It has since
been clearly demonstrated that IDPs are prevalent in eukaryotic
proteomes [19], are involved in signaling and regulation [20,21],
carry sites of posttranslational modifications [22,23], and serve as
hubs in protein interaction networks [24,25,26]. Despite their
important functional roles [27,28,29,30,31], IDRs generally have
low sequence conservation [32], with the exception of IDRs
involved in chaperone activity and RNA binding [33]. IDPs have
been implicated in many human diseases, including cancer,
diabetes, cardiovascular and neurodegenerative disorders [20,34].
Due to their signaling and regulatory roles, IDPs tend to be tightly
regulated, and disruptions in regulation of IDPs have been linked
to disease [35]. Despite the functional importance and disease
relevance of IDPs, the prevalence of disease-associated missense
mutations in disordered regions and their impact on disordered
conformations have not been investigated so far.
Here, we offer a new perspective on disease mutations that
accounts for mutations in disordered regions. We investigate
disease-associated mutations located in ordered and disordered
regions, and compare them to missense mutations from two
control datasets, single amino acid polymorphisms and neutral
evolutionary substitutions. We demonstrate that deleterious
missense mutations may affect disordered regions, thereby
disrupting the disorder-based type of structure. Our results suggest
that disease mutations in ordered regions (ORs) and IDRs differ
substantially in frequency, properties, and functional impact. We
find that disease mutations in disordered regions more frequently
cause predicted disorder-to-order transitions and influence pre-
dicted disordered binding regions (MoRFs) compared to mutations
from the control datasets. IDR mutations are also enriched in
DNA-binding and transmembrane domains, and in sites of
posttranslational modifications. Accelerated molecular dynamics
simulations performed on a deleterious disorder-to-order transi-
tion mutation that affects the DNA-binding domain of tumor
protein p63 support our disorder predictions. We further show
that two widely used predictors of functional impact of single
nucleotide variants, PolyPhen-2 and SIFT, exhibit a .10%
decrease in sensitivity when predicting the effect of annotated
disease mutations located in IDRs compared to ORs mutations.
Our findings have broad implications for improving predictors of
the functional impact of missense mutations and therefore may
significantly influence the interpretation of novel variants identi-
fied in large genome sequencing projects.
Results
Mutation frequencies in ordered and disordered regions
We examined the frequency of annotated disease mutations
(DM) from the UniProt database in predicted ordered and
disordered regions and compared them to the distributions of
putatively functionally neutral mutations from two control
datasets, annotated polymorphisms from UniProt (Poly) and
neutral evolutionary substitutions (NES) (Materials and Meth-
ods). We observed that disease mutations preferentially affect
ordered regions, with 78.3% of them mapped to the predicted
ordered regions and 21.7% mapped to the predicted disordered
regions (Table 1). Neutral evolutionary substitutions are more
evenly distributed, with 55.3% observed in ORs and 44.7% in
IDRs (Table 1). The annotated polymorphisms show somewhat
intermediate distribution, with 59.6% in ORs and 40.4% in IDRs.
Enrichment of disease mutations in ordered regions agrees with
previous observations that disease mutations frequently affect
protein structure, activity and stability [4,7]. Our results were
consistent across three disorder predictors, VLXT [36], VSL2B
[37] and IUPRED [38] (Table S1).
The enrichment of disease mutations in ORs cannot be
explained by the overall lower disorder content of the proteins
containing these mutations. Although proteins that carry disease-
associated mutations are on average slightly less disordered than
proteins from the Poly dataset (mean6SD 32.7617.9% vs
35.3619.5%, respectively; also see Figure S1), this difference is
not sufficient to explain the 3.6 fold enrichment of disease
mutations in ORs. Furthermore, despite the fact that the NES
dataset was constructed from the same set of proteins as DM
(Materials and Methods), only a 1.2 fold enrichment of
mutations in ORs compared to IDRs is observed in this dataset
(Table 1), which lends further support to enrichment of disease
mutations in ORs. Finally, we compared mutation rates (number
of amino acid changes per ordered and per disordered residue) in
ORs and IDRs in all three datasets, and only in the DM dataset
the mutation rate in ORs was higher than the mutation rate in
IDRs (Table 2).
Despite the prevalence of disease mutations in ordered regions,
21.7% of DMs are mapped to the predicted disordered regions.
We have investigated these mutations in greater detail, as
Table 1. Disease mutations have higher frequencies in
ordered regions.
IDR OR
Dataset Proteins Mutations n % n % Fold
DM 2,194 15,459 3,356 21.7 12,103 78.3 -
Poly 8,489 24,220 9,790 40.4 14,430 59.6 0.54
NES 1,998 60,299 26,927 44.7 33,372 55.3 0.49
doi:10.1371/journal.pcbi.1002709.t001
Author Summary
Intrinsically unstructured or disordered proteins have been
implicated in the etiology of a wide spectrum of diseases.
However, the molecular mechanisms that relate mutations
in intrinsically disordered regions (IDRs) to disease path-
ogenesis have not been investigated. Disordered proteins
do not conform to the prevailing view of deleterious
mutations which equates function, structure and evolu-
tionary conservation – intrinsically disordered regions are
functional, but lack a fixed three-dimensional structure and
in general have low sequence conservation. Here we
demonstrate that .20% of disease-associated missense
mutations affect IDRs and interfere with their functions.
We further show that 20% of deleterious mutations in IDRs
induce predicted disorder-to-order transitions. Our predic-
tions are supported by accelerated molecular dynamics
simulations that show an increase in helical propensity of
the region harboring a disease disorder-to-order transition
mutation of tumor protein p63. Our results refine the
traditional structure-centric view of disease mutations and
offer a new perspective on the role of non-synonymous
mutations in disease. Our findings have broad implications
for improving predictors of the functional impact of
missense mutations, and for interpretation of novel
variants identified in large genome sequencing projects
that aim to provide a better understanding of human
genetic variation and its relevance to common diseases.
Disease Mutations in Disordered Regions
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discussed below, and mutations in IDRs form the main focus of the
remainder of this study.
Disorder-to-order (DRO) and order-to-disorder (ORD)
transition mutations
Based on the predicted disorder probability score, a residue can
be classified as ordered or disordered depending on whether its
score is below or above a threshold of 0.5. When analyzed from an
order/disorder perspective, any missense mutation can have two
different outcomes: (i) it can change the prediction score
sufficiently to cross the 0.5 threshold, which would result in a
conversion of the prediction from disorder to order, or from order
to disorder; or (ii) it can preserve the order/disorder assignment.
Thus, the effect of missense mutations can be classified as DRD
(disorder-to-disorder) or ORO (order-to-order) when disorder and
order assignments do not change; and as DRO (disorder-to-order)
or ORD (order-to-disorder) transitions when predicted disorder
and order classes switch.
Disease mutations mapped to disordered regions cause DRO
transitions significantly more frequently than neutral evolutionary
substitutions or polymorphisms (Table 2). We observed that 20%
of the disease mutations in disordered regions result in a DRO
transition, compared to only 11.5% and 7.3% in the Poly and
NES control sets (Fisher’s exact P=1.06?10232 and 5.47?102105,
respectively). In contrast, the rates of ORD transition show no
change or a slight depletion in DM compared to Poly and NES,
respectively (Table 2). Similar results were obtained using three
different disorder predictors (Table S3). These observations
suggest that disease mutations in disordered regions are more
likely to cause a significant structural perturbation, and possibly
disrupt functions that necessitate protein disorder. Below, we
examine the structural and functional implications of disease
mutations in greater detail.
Secondary structure predictions and mutations
To better understand how disease mutations influence protein
secondary structure, we applied the secondary structure predictor
PHD [39] to both the disease and control datasets. In each dataset,
we calculated the frequencies of secondary structure elements
(helices, strands and loops) and transitions between them upon a
mutation. Overall, we observed that disease mutations affect
helices and strands more frequently than control mutations
(Table S4). We also observed that although most mutations do
not cause a change in the assignment to a predicted helix, strand
or loop, there is nevertheless a statistically significant increase in
transitions between secondary structure elements caused by
disease mutations compared to the control datasets (Table S5).
This increase was most pronounced for transitions from helices
and strands into loops, and to a lesser extent for transitions from
loops into helices and strands (Figure 1). There was no significant
difference between disease and control mutations for transitions
from helix into strand and vice versa (Figure 1). Although similar
trends are observed for loops predicted by PHD and disordered
regions predicted by VLXT, VSL2B and IUPred (see Figure 1,
Table 2 and Table S3), it is important to note that predicted
regions of disorder and loops do not necessarily overlap [40,41],
and that many secondary structure elements predicted by PHD
are found within experimentally verified disordered regions
[40,42,43].
Despite the lack of stable secondary and tertiary structure in
disordered regions, the dynamic behavior of IDRs does not
preclude formation of short transient secondary structure ele-
ments. These short transient elements, or Molecular Recognition
Features (MoRFs) [44], frequently mediate interactions of IDRs
with their physiological binding partners [44,45,46]. Below, we
investigated the influence of missense mutations on MoRFs.
Disease mutations in predicted a-MoRF regions
Molecular recognition features (MoRFs) are short order-prone
segments within longer disordered regions that fold upon binding
to their interaction partners [47]. a-MoRFs specifically form a-
helices upon binding. We predicted the presence of a-MoRFs at
the position of the residue both before and after it was mutated,
and classified the mutation as falling into one of the three
categories: (i) ‘‘predicted MoRF lost’’ - an a-MoRF was predicted
to overlap the position of the mutated residue in the wild-type
sequence but not in the mutant sequence; (ii) ‘‘predicted MoRF
gained’’ - an a-MoRF was predicted not to overlap the position of
the mutated residues in the wild-type sequence but was predicted
to overlap the position of the mutated residue in the mutant
sequence; (iii) ‘‘MoRF present, no change’’ - an a-MoRF was
predicted to overlap the mutated position in both the wild-type
and the mutant sequences. Mutations where an a-MoRF was
absent from both wild-type and mutant sequences were not taken
into account. Amino acid substitutions were placed into IDR and
OR categories based on the wild-type disorder score. Details of
MoRF predictions are provided in the Materials and Methods
and in the Supplementary Text S1.
IDR mutations lead to gain or loss of predicted a-MoRFs 2.2 to
5.1 times more frequently than OR mutations, independent of the
dataset used (Figure S2). Disease mutations in IDRs lead to a loss
of predicted a-MoRFs 1.39 times more frequently than Poly and
1.36 times more frequently than NES (Fisher’s exact P=0.0012
and 7.9?1024, respectively). Disease mutations in ORs have an
opposite effect – they lead to a gain of predicted a-MoRFs 1.5-fold
more frequently than Poly and 1.8-fold more frequently than NES
(P=0.0020 and 1.65?1025). A follow up investigation showed that
DRO and ORD mutations significantly contribute to the
observed effect (Figure 2). Disease DRO mutations lead to a
loss of predicted a-MoRFs 2.1-fold more frequently than Poly and
NES (P=1.11?1024 and 5.68?1025), and similarly disease ORD
Table 2. Disorder-to-order transition mutations are significantly enriched in disease.
DRO DRD ORD ORO
Dataset n % n % Fold P-value n % n % Fold P-value
DM 670 20.0 2,686 80.0 - - 590 4.9 11,513 95.1 - -
Poly 1,125 11.5 8,665 88.5 1.7 1.06610232 710 4.9 13,720 95.1 1.0 0.89
NES 1,971 7.3 24,956 92.7 2.7 5.476102105 1,870 5.6 31,502 94.4 0.9 0.0023
P-values were calculated using Fisher’s exact test between mutation counts in DM and Poly or NES.
doi:10.1371/journal.pcbi.1002709.t002
Disease Mutations in Disordered Regions
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mutations lead to a gain of predicted a-MoRFs 1.7-fold more
frequently than Poly and 2.0-fold more frequently than NES
(P=0.025 and 0.0012).
Disease mutations in eukaryotic linear motifs (ELMs)
We also examined the influence of disease and control
mutations on Eukaryotic Linear Motifs (ELMs), short (3 to 11
residues) conserved sequence motifs that play roles in mediating
cell signaling, controlling protein turnover and directing protein
localization [48]. ELMs were previously shown to be enriched in
IDRs [49]. We mapped mutations from the three datasets onto
1040 annotated ELM instances from human proteome (see
http://elm.eu.org/elms/browse_instances.html) and found that
only 99 mutations overlap an ELM. Although disease DRO
mutations were slightly enriched in ELMs in comparison to
control DRO mutations (Table S6), this difference reached
statistical significance only for DM vs NES (P= 0.012), but not for
DM vs Poly (P= 0.22), likely due to a limited number of
observations. We did not observe any differences for other classes
of mutations. Although a decisive conclusion about enrichment of
DRO disease mutations within ELMs could not be made at this
point, we believe that the trend towards such enrichment warrants
further investigation when larger numbers of ELMs and annotated
mutations become available.
Functional characterization of disease mutations in IDRs
and ORs
To characterize the functional impact of missense mutations, we
examined UniProt region/residue feature annotations associated
with each mutation (Materials and Methods). A number of
functional annotations for disease mutations in IDRs and ORs
show significant differences in fold enrichment (Figure 3). Disease
mutations in disordered regions are enriched in domains and
functions associated with DNA binding motifs (homeobox, zinc
finger, basic motif), transmembrane domains, sites of post-
translational modifications, disulfide bond formation, and triple
helical regions, which are often found in cytoskeletal and coiled-
coil proteins. Some of these functional categories were previously
strongly associated with disordered regions [28,30], and many
DNA-binding domains are known to be either entirely or partially
disordered when not associated with DNA [50,51,52]. Further
investigation of keywords associated with DRO transitions shows
an enrichment of functions similar to IDR, while ORD transition
mutations show enrichment in ABC transporter and ATP-binding
regions (Tables S7 and S8).
DRO and ORD mutation patterns are different
In order to investigate mutations that contribute to the observed
DRO and ORD transitions, we calculated the ‘‘wild-type
residueRmutant residue’’ transition matrices in all three datasets
and compared the differences in frequencies of DRO (Figure 4,
first row) and ORD (Figure 4, second row) mutations between
DM and Poly (Figures 4A and 4C), and DM and NES
(Figures 4B and 4D). We observe that certain residue-into-
residue substitutions are enriched (red), while others are depleted
(green) in disease. Arginine (R) is the most frequently mutated
residue in the DRO dataset, and leucine (L) is most frequently
mutated in the ORD dataset. The overall results do not depend
on the choice of the control dataset (Poly or NES).
Figure 1. Transitions between helices (H), strands (E) and loops (L) upon mutations from three datasets, based on PHDsec
predictions. Transitions from helix or strand to loop and vice versa are significantly enriched in disease. P-values were calculated using Fisher’s exact
test between mutation counts in DM vs Poly or NES. Categories with Bonferroni-corrected P-values,0.05 are marked with an asterisk.
doi:10.1371/journal.pcbi.1002709.g001
Figure 2. Disease DRO transition mutations lead to the loss of
predicted a-MoRFs (panel A), while ORD transition mutations
lead to the gain of predicted a-MoRFs (Panel B) significantly
more frequently than control mutations. Y-axes show fractions of
all DRO and ORD mutations that cause loss or gain of the predicted a-
MoRFs, and error bars correspond to one standard deviation.
doi:10.1371/journal.pcbi.1002709.g002
Disease Mutations in Disordered Regions
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The heat plots in Figure 4 point to specific mutations that are
highly enriched in disease. The most frequent disease mutation
that causes a disorder-to-order transition is RRW (Figure 4C).
Other DRO transition mutations significantly enriched in the
DM dataset include most notably RRC, RRH, ERK, RRQ
(Figure 4E, left section). Several other types of disorder-to-order
transition mutations, such as RRK, ERD, LRF, SRT, are
significantly depleted in the DM dataset (Figure 4E, right
section), which demonstrates that distinct types of mutations
preferentially occur within disease and control categories.
To verify that this result is not an artifact of our analysis, for
example due to general enrichment of RRW mutations in
disordered regions, or the choice of control datasets, we have
compared the frequencies of RRW substitutions from this study to
the matrices constructed based on the alignments of completely
disordered sequences [53]. This comparison showed that in
general RRW substitutions occur extremely rarely in disordered
regions (with 0.11% in D85 matrix and 0.03% in D40 matrix),
whereas we find RRW substitution with much higher frequency
in our datasets (11.69% in DM, 6.52% in Poly, and 0.95% in
NES). This result suggests that the RRW mutation is truly
enriched among disease mutations.
Another category of amino-acid substitutions in DM, albeit not
significantly enriched as a group, involve order-to-disorder
mutations, such as LRP, CRR, GRR, WRR and others
(Figure 4F). Some of the enriched order-to-disorder mutations
are inverses of the enriched disorder-to-order mutations, such as
WRR, CRR, LRR, whereas some are shared between DRO
and ORD, such as GRE. This shared category points to the fact
that there is no strong preference for glycine and glutamic acid to
be located in either ordered or disordered regions, as reflected by
the presence of both residues in the middle of the TOP-IDP scale
of residue disorder propensities [54].
In summary, our analysis shows that a limited set of mutations
accounts for a large fraction of all DRO and ORD transitions in
the DM dataset. The top five disorder-to-order transition
mutations (RRW, RRC, ERK, RRH and RRQ) collectively
account for 44.0% of all DRO disease mutations, and the top five
order-to-disorder transition mutations (LRP, CRR, GRR,
WRR and FRS) collectively account for 32.2% of all ORD
Figure 3. Fold differences of UniProt FT annotations in DM compared to Poly (panels A,C) and NES (panels B,D) that show
statistically significant frequency difference between mutations in IDR and OR. Top row (A, B) contains level 1 and the bottom row (C, D)
level 2 features. Error bars are one standard error of fold difference. Categories are sorted by decreasing fold difference in DM compared to controls.
doi:10.1371/journal.pcbi.1002709.g003
Disease Mutations in Disordered Regions
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Figure 4. Enrichment and depletion of DRO (panels A, B, E) and ORD (panels C, D, F) mutations as % of disease mutations in
comparison to % of polymorphisms (Poly; panels A, C) and % of neutral evolutionary substitutions (NES; panels B, D). In the
heatplots (panels A, B, C, D) wild-type residues are on the Y-axes and the mutant residues on the X-axes. The residues are arranged according to the
Disease Mutations in Disordered Regions
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disease mutations (Figure 4C and 4F). Specific knowledge of the
mutations responsible for such transitions may help the develop-
ment of new classifiers to better predict the effects of mutations in
IDRs.
Arginine is the most frequently mutated residue in DM
We next compared the frequencies of wild-type and mutant
residues in all datasets to the frequencies of typical human proteins
from the UniProt database (Figure S3). Mutations of arginine
and glycine are most dominant in DM and account for 28.5% of
all disease mutations, 18.6% of all Poly and only 11.1% of NES
mutations (Figure S3B). After normalizing by the baseline residue
frequency [55] (Figure S3A), mutations of cysteine and trypto-
phane stood out, reflecting that in DM these two resides are
mutated significantly above what is expected based on their
frequency of occurrence in the human proteome. Interestingly,
tryptophane and cysteine, and to a lesser degree histidine, are the
residues into which other residues most frequently mutate, with a
more pronounced effect in IDRs than in ORs (Figure S4).
High mutability of arginine, also observed in earlier studies
[56,57], together with the high propensity of arginine
mutations to cause disorder-to-order transitions suggest
an underlying mechanism which predisposes arginine to be a
frequent target for disease mutations. Arginine is encoded by 6
distinct codons, 4 of which contain the CG dinucleotide (CGG,
CGT, CGC and CGA). DNA methylation often involves CpG
dinucleotides and due to spontaneous deamination 5-methylcyt-
osine is more prone to mutating into T. Upon a C-to-T transition,
the first three arginine codons would become codons for W (TGG)
or C (TGT, TGC), and the last one would create a stop codon
(TGA). The observed high frequency of RRW and RRC in DM
and low frequency in control datasets (Figure S5) argues in favor
of negative selection against these amino acid substitutions, which
frequently cause predicted disorder-to-order transitions in pro-
teins.
Mutations in IDRs are less accurately predicted
A recent study demonstrated that SIFT has a higher error rate
when predicting the impact of SNVs in solvent accessible and
disordered protein regions [14]. In order to rigorously evaluate this
statement, SIFT [10] and PolyPhen-2 [58] were applied to all
mutations in DM, Poly and NES datasets, and the prediction
accuracies on mutations in different order/disorder categories
were compared (Figure 5 and Table S9). Both SIFT and
PolyPhen-2 predict significantly less disease mutations as delete-
rious in IDRs than in ORs (SIFT ‘‘damaging’’ 64.3% vs 74.4%, x2
P=4.19?10228; PolyPhen-2 ‘‘probably damaging’’ 60.8% vs
74.9%, P=8.05?10274). SIFT and PolyPhen-2 both predict
significantly more polymorphisms to be benign in IDRs than in
ORs (SIFT ‘‘tolerated’’ 78.7% vs 73.5%, P=1.86 ?10218;
PolyPhen-2 ‘‘benign’’ 55.5% vs 53.7%, P=3.74 ?10264), and
likewise for neutral evolutionary substitutions (SIFT 91.6% vs
87.9%, P=7.38?10245, PolyPhen-2 80.2% vs 75.6%,
P=2.84?102215). IDR mutations seem to be more difficult to
handle for the PolyPhen-2 model in general, and in all three
datasets more IDR than OR mutations are returned as
‘‘unknown’’ (DM 4.4% vs 1.2%, Poly 7.5% vs 3.4%, NES 8.7%
vs 2.4%). Upon closer examination, we determined that among
DM mutations, the DRD transition category was the most
difficult to predict correctly for both predictors, while the DRO
category was most often correctly predicted as deleterious.
However, in the case of DRO mutations, higher sensitivity comes
at the expense of lower specificity, and significantly more
mutations from Poly and NES are predicted as deleterious in
DRO transitions than in any other category (Table S9). Similar
results were obtained by analyzing raw PolyPhen-2 and SIFT
scores (Figures S6 and S7). Notably, the DM dataset investigated
here overlaps with the predictors’ training sets, and the reported
accuracies are likely to be lower when applied to out-of-training set
examples. In summary, our findings underscore the need for
incorporating features of IDRs into predictive disease mutation
models.
Accelerated molecular dynamics simulations of p63
DRO mutation
We observed 670 mutations in UniProt predicted to cause
DRO transitions, and 590 mutations predicted to cause ORD
transitions (Tables S10 and S11). We note that the number of
such examples would be higher if extensively studied proteins with
an excessively large number of mutations (such as p53, androgen
receptor, etc.) were included in the analysis (Materials and
Methods and Figure S8). In addition to disease mutations
mapped to predicted disordered regions, we elsewhere summa-
rized DRO disease mutations found in the experimentally
ascertained disordered regions from the DisProt database [59].
Below, we show an example of a protein carrying predicted DRO
disease mutation (Figure 6).
Tumor protein p63 (TP63) is a transcription factor involved in
development and morphogenesis of epithelial tissues [60,61]. The
sequence, structure and domain organization of p63 are highly
similar to tumor suppressor protein p53, with the exception of two
additional domains at p63 C-terminus, which are alternatively
spliced in some p63 isoforms. More than 30 distinct missense
mutations have been identified in p63 and associated with several
malformation genetic syndromes such as ectrodactyly ectodermal
dysplasia-cleft syndrome 3 (EEC3, MIM: 604292), split hand/foot
malformation-4 (SHFM4, MIM: 605289), and nonsyndromic cleft
lip (NSCL, MIM: 129400). Most of the mutations that cause
EEC3 occur within the DNA-binding domain of p63 [62]. One of
these mutations, R243W, is predicted to cause a DRO transition,
shown in Figure 6A as a sharp drop in disorder score of the 235–
245 region (red dotted line) after R243 has been in silico mutated to
W. Since R243 is not directly involved in binding to DNA, the
mutations affecting this residue are predicted to destabilize the
protein as a result of hydrogen bond loss and overpacking [63].
DNA-binding domains of transcription factors tend to be
predicted as fully or partially disordered [64,65], and binding to
DNA typically induces a DRO transition [66]. In agreement with
these observations, only a single NMR structure of p63 DBD
without DNA (PBD: 2RMN) is available, while all X-ray structures
of p63 DBD found in PDB (PDB: 3US0, 3US1, 3US2, 3QYM and
3QYN) have been crystallized in complex with DNA. Residue
R243 is located in the modeled turn region of the NMR structure,
adjacent to a short a-helix. We investigated the effects of the
R243W mutation on p63 DBD conformation using an extensive
set of accelerated molecular dynamics (AMD) simulations [67,68]
on both the wild-type p63 (wt-p63) and its R243W mutant.
Vihinen flexibility scale [83]. In panels E and F, frequencies of top ten DRO (panel E) and ORD (panel F) mutations enriched and depleted in the DM
dataset are shown. * signify Fisher’s exact P-values of DM vs. Poly; + signify p-values of DM vs. NES. *** or +++ 2 P,0.001; ** or ++ 2 P between
0.001–0.01; * or + 2 P between 0.01–0.05.
doi:10.1371/journal.pcbi.1002709.g004
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AMD is an efficient and versatile enhanced conformational
space sampling algorithm that has previously been successfully
applied to the study of the conformational behavior of IDPs
[69,70]. A comparative analysis of a series of AMD trajectories
for wt-p63 and its R243W mutant revealed no significant
differences in the global structural dynamics of the p63 DBD.
However, marked differences in the conformational behavior of
residues adjacent to R243W were observed (Figure 6B). The
introduction of R243W mutation caused a significant increase in
the free energy weighted w/y propensity of the a-helical/
frustrated a-helical conformation of these residues, resulting a-
helical population statistics of 70–90% and 30%–50% in the
R243W mutant for residues 236–240 and 241–243 respectively,
compared to 20%–60% and 20–25% in the wild-type system
Figure 5. Distribution of PolyPhen-2 (panels A, C, E) and SIFT (panels B, D, F) calls for mutations in DM, Poly and NES datasets. Both
predictors show a drop in sensitivity for disease mutations in IDR and DRD categories (A, B) and a drop in specificity for DRO mutations in Poly (C,
D) and NES (E, F).
doi:10.1371/journal.pcbi.1002709.g005
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(Table S12). The formation of an ostensibly exclusive (frustrated)
a-helical coil in this region in the presence of the R243W
mutation is fully consistent with the predicted DRO transition
(Figure 6A).
It is interesting to note that in both the experimental NMR
structure and the AMD simulations for wt-p63 the side-chain of
R243 forms a strong salt-bridge with E252. One may postulate
that in the wild-type system the strong electrostatic interaction
between R243 and E252 introduces tensile stress in the extended
loop region K232-R243, which exhibits conformational exchange
on slow time-scales between local extended b-sheet/PPII and a-
helical constructs. By contrast, the introduction of the R243W
mutation removes the tensile strain from the loop facilitating the
formation of a stable a-helix.
Figure 6. Disorder predictions and the effect of a R243W missense mutation in human protein p63. (A) PONDR VLXT disorder
predictions for wild type and mutant p63. R243W mutation causes drop in the disorder score of 235–245 region. (B) Differential free energy weighted
w/y propensity plots for residues 235–243 obtained from AMD simulations performed on the wild-type and R243W mutant p63 DBD systems. The red
dots represent those regions of the Ramachandran plot more heavily sampled by the mutant and the black dots represent those regions with greater
propensity in the wild-type system.
doi:10.1371/journal.pcbi.1002709.g006
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Discussion
The widely accepted structure-centric view of deleterious
mutations asserts that a disease may be caused by mutations
disrupting protein activity, stability, oligomerization and other
structure-based properties. Here, we further extend this concept
by introducing a disorder-centric view of disease mutations,
according to which a disease may arise due to a disruption of the
disorder-based protein properties [59]. We have demonstrated
that a substantial fraction of disease-associated muta-
tions are located within the intrinsically disordered
protein regions, and that disease mutations in IDRs
have a significant functional impact despite the fact that
IDRs lack fixed structure and have fewer evolutionary constraints
than ORs [32]. The analysis of mutations in IDRs shows that
disorder-to-order transition mutations may be especially relevant
to disease due to their enrichment compared to control datasets. In
addition, our analysis suggests that several types of disease
mutations may have particularly critical impact on disordered
structure.
There are many ways in which mutations in IDR may increase
disease risk or cause a disease. For example, DROmutations have
a potential to alter interactions with DNA, RNA, proteins or
ligands. Both, our results and those of a recent study by Dan et al.
[71], which examined transitions between disorder and secondary
structure in proteins with solved 3D structures, converged on the
observation that disorder-to-order (i.e. disorder-to-secondary
structure in [71]) transitions are significantly enriched in DNA
binding proteins. In addition, mutations in IDR could influence
posttranslational modifications, assembly of macromolecular
complexes, as well as signaling and regulatory processes that
depend on disorder. Adding support to this hypothesis is an
observation that disease mutations often disrupt anchoring of
flexible loops of the catalytic domains in protein kinases, and that
mutated residues are frequently involved in substrate binding and
regulation [72]. This also suggests a potential downstream effect of
mutations in IDR via dysregulation of cellular pathways which
could lead to disease [59].
Our results show that across all three datasets, mutations in IDR
are more likely to cause a predicted DRO transition than
mutations in ORs are to cause a predicted ORD transition
(Table 2). This is in agreement with a recent study by Schaefer
et al. [73], which showed that disordered regions are more sensitive
to mutations than protein regions with defined secondary
structure, with a caveat that ‘‘order’’ and ‘‘helix or strand’’ cannot
be fully equated. Despite a significant enrichment of DRO
mutations in disease, the majority of disease mutations in IDR do
not result in a disorder-to-order transition (as defined in this paper)
but they nonetheless sufficiently disrupt the disordered conforma-
tion to affect disorder-mediated functions. It is likely however that
many other mutations that do not reach the disorder-to-order
transition threshold may still disrupt the structure and conse-
quently function of the disordered regions.
Our findings have wide implications for large genome
sequencing projects that aim to provide a better understanding
of human genetic variation and its relevance to complex diseases
[1]. Because the sheer volume of the observed variants precludes
systematic functional follow-up studies on each one individually,
newly identified SNVs are short-listed and prioritized using
predictors of the functional impact of SNVs, such as SIFT,
PolyPhen-2 and others [2]. The majority of the currently used
predictors are structure- and/or conservation-based, and therefore
less accurate on variants in unstructured and non-conserved
protein regions. Disorder predictions could be either integrated
into current approaches, or new approaches, which analyze the
features of mutations in ORs and IDRs separately, could be
developed. In addition, in this study we demonstrate that specific
types of mutations (such as RRW, RRC, etc.) account for almost
one half of all DRO transitions (Figure 4). This additional
information may be important to include as a training feature
when developing new predictors for the effects of DRO SNVs.
A broader issue raised by our results is that caution should be
exercised when interpreting the relationship between structure,
function and conservation. A study by Yue and Moult found
that human disease-relevant mutations in some cases could
correspond to the wild-type variants in the mouse [11].
Compensatory mutations [74] illustrate that function cannot
be fully equated with the ‘‘first order conservation’’, and that
sometimes co-evolution of amino acids constrained by protein
structure necessitates looking into the ‘‘second order conserva-
tion’’ between pairs of residues. Our results are consistent with
the fact that IDRs are less conserved at any individual position,
but rather show a conservation of disorder propensity within a
region [75], with DRO transition mutations – detrimental to
conservation of disorder – being particularly enriched in
disease.
Choosing an appropriate control for the analysis of disease
mutations is an issue which deserves close attention [76]. One of
our control datasets, polymorphisms from UniProt (Poly), is likely
to contain a fraction of as yet unannotated disease mutations,
because it was assembled by translating missense single nucleotide
variants (currently without any disease associations) into single
amino acid changes [76,77]. This is further supported by the
predictive result that between 20% [7] and 25% [11] of non-
synonymous SNPs are likely to be associated with diseases.
Nonetheless, Poly controls for an important previously identified
confounder: because disease missense mutations are translations of
a single nucleotide variation within a DNA codon, a genetically
appropriate control has to be analogously constrained by the
genetic code, that is, assembled from amino acid changes which
are translations of functionally neutral SNVs [57,76]. In the
protein space, another concern is that length distribution and
amino acid compositions of proteins from DM and Poly datasets
differ, which may influence their baseline biochemical properties,
including disorder content (Figure S1). In order to address this
potential confounder, the second control (NES) was generated
starting with the sequences of proteins from the DM dataset. The
downside of this approach is that the set of disease mutations spans
within-population differences, while changes in the orthologs span
larger, inter-species distances. In practice, this means that in DM
and Poly the mutation probability matrix is dominated by the
effects of the genetic code, while in DM and NES it is dominated
by effects of physico-chemical similarity between amino acids.
Nonetheless, variants fixed between species are likely to be non-
deleterious (even though about 9% of interspecies substitutions
have been estimated to be damaging [7]), and therefore they
provide a useful additional control that takes into account
sequence conservation. In the light of advantages and shortcom-
ings of different control datasets, it is reassuring to see that when
using either Poly or NES, protein disorder-related properties
(Tables 1 and 2) and WT-to-mutant amino acid changes
(Figure 4) are consistent and independent of the control dataset
used. In addition, the preponderance of annotated mutations
within OR might show some degree of ascertainment bias since
some disease mutations were annotated as ‘‘disease’’ because they
were mapped to protein structured domains. We hypothesize that
an unbiased sample would contain a higher proportion of disease
mutations that map to IDRs.
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In summary, our results refine the traditional structure-centric
view of disease mutations, and suggest new avenues for research in
the area of protein disorder. With the recent explosion of exome
and whole genome sequencing efforts, interpretation of the
identified variants will require highly accurate predictors for the
functional impact of SNVs in order to make reliable conclusions
about their health risks. Our results offer help in narrowing down
the gamut of disease mutations that dramatically influence protein
structure and disorder. We hope that it will also facilitate
predictions of the influence of mutations on protein function,
which is currently a formidable task. The importance of mutations




A list of single amino acid substitutions annotated with the
keyword ‘‘disease’’ was extracted from the UniProt/SwissProt
database [77]. This manually curated catalog contains missense
mutations associated with both Mendelian and complex diseases,
but no nonsense nor frame shift mutations, and no products of
alternative splicing.
The initial set of mutations was filtered as follows: proteins that
carry disease mutations and have $40% pairwise sequence
identity were clustered using hierarchical clustering with single
linkage, and one representative protein was selected at random
from each cluster. We further removed four proteins with an
unusually high number of annotated disease mutations (Figure
S8A): tumor suppressor p53 (P04637), coagulation factor VIII
(P00451), androgen receptor (P10275), and Stargardt disease
protein (P78363). Taken together, these four proteins account for a
total of 12.4% of all disease mutations found in the non-redundant
set of proteins. All mutations from the removed proteins were
discarded.
We assembled two control datasets: (1) annotated single amino
acid polymorphisms from UniProt (Poly) [77] and (2) a set of
pseudo-mutations based on amino acid variation in mammalian
orthologous proteins (neutral evolutionary substitutions, NES).
The first control dataset (Poly) was filtered analogously to disease
mutations, and redundant proteins and titin (with unusually high
number of polymorphisms) were removed (Figure S8B).
The second control dataset (NES) (Figure S8C) was construct-
ed following the approach of Sunyaev et al. [78]. Proteins that
carry disease mutations which also passed our filtering criteria
were aligned by the use of multiple sequence alignment program
MUSCLE [79] against their InParanoid [80] orthologs from 10
mammalian species (P. troglodytes, P. pygmaeus abelii, M. musculus, M.
mulatta, C. familiaris, E. caballus, R. norvegicus, C. porcellus, B. taurus,
and M. domestica), using the BLOSUM85 matrix. The set of neutral
evolutionary substitutions (NES) was assembled from all single
amino acid differences in orthologous proteins that had $95%
sequence identity with the human disease protein. Finally, all
annotated disease mutations were filtered out from the NES
dataset. The numbers of proteins and mutations in the three
datasets are summarized in Table 1.
Disorder predictions
Protein disorder was predicted using VLXT [36], VSL2B [37]
and IUPRED [38]. Disorder predictions were carried out on full
length wild-type (WT) and mutated protein sequences, generated
by changing only one residue at a time. Disorder score ,0.5
signified predicted order and $0.5 signified predicted disorder.
We defined the effect of a mutation as a disorder-to-order (DRO)
transition if the prediction score for a residue to be mutated was
$0.5 in the WT protein, and ,0.5 after the mutation. Order-to-
disorder (ORD) transitions were analogously defined. The
enrichment/depletion trends for DRO and ORD transitions
are consistent across all three predictors (Tables S1 and S3).
As a second comparison of disorder predictors, we examined the
distributions of the difference between disorder prediction scores
on WT and mutated sequences, defined as Dps = ps(WT
residue)2ps(mutated). The three predictors have different ob-
served dynamic ranges for Dps: [20.91, 0.85] for VLXT, [20.34,
0.39] for VSL2B and [20.28, 0.27] for IUPRED, consistent with
the fact that VLXT is more sensitive to small changes in amino
acid sequence. Distribution of Dps is more platykurtic in DM
compared to Poly and NES for all three predictors (higher % of
disease-associated mutations in the tails), indicating that disease
mutations tend to cause stronger differences in prediction scores.
Secondary structure predictions
Secondary structure was predicted from sequence using
PHDsec [81]. We used only reliable predictions, defined as
having both a ‘‘from’’ and ‘‘to’’ secondary structure assignment
score $4. We note, however, that the trend was the same when all
secondary structure predictions were used without thresholding on
the reliability score.
a-MoRF predictions
a-MoRFs were predicted from sequence using a two stage
stacked prediction method [44]. The first stage identified potential
a-MoRF regions from PONDR VLXT [36] predictions by
scanning for short predicted ordered regions flanked by predicted
disordered regions. The second stage classified potential a-MoRF
regions as either a-MoRFs or non-a-MoRFs using a quadratic
discrimination model [44]. Further details of a-MoRF predictions
are provided in the Supplementary Text S1.
Functional characterization
Residues were functionally annotated using the UniProt/
SwissProt feature table (FT) at two levels of granularity, the FT
keywords only (level 1) and concatenations of the FT keyword and
description (level 2). Features marked as ‘‘Potential’’, ’’Probable’’
or ‘‘By similarity’’ were removed. The ‘‘Description’’ field was
normalized by removing prefixes such as ‘‘For’’, ‘‘Required for’’,
‘‘Sufficient for’’, ‘‘Essential for’’, ‘‘Essential to’’, ‘‘Important for’’,
‘‘Critical for’’, ‘‘Necessary for’’, ‘‘Involved in’’, ‘‘Mediates’’, etc.
Finally, all features that occurred ,5 times in DM were removed.
After this process, 22 level 1 and 782 level 2 features remained. We
removed all disease keywords from this analysis, since they would
be trivially enriched in the DM dataset.
Molecular dynamics simulations
Standard classical and accelerated molecular dynamics simula-
tions were performed on both wild-type and R243W p63 mutant
using an in-house modified version of the AMBER-10 simulation
suite [82]. The reader is referred to the Supplementary Information
(Supplementary Text S2) for a description of the accelerated
molecular dynamics method and computational details.
Supporting Information
Figure S1 Histograms of the distribution of proteins in DM and
Poly datasets with x% of residues predicted to be disordered by
VLXT. The lower mode and shorter right tail of the DM
distribution indicates that on average proteins carrying disease-
associated mutations (DM) are less disordered than proteins
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carrying polymorphisms (Poly) (mean6SD 32.7617.9% disorder
vs 35.3619.5%).
(TIF)
Figure S2 Summary of the effect of mutations in DM, Poly,
NES on predicted molecular recognition features (a-MoRFs).
Disease DRO transition mutations lead to a loss, while ORD
transition mutations lead to a gain of predicted MoRFs,
significantly more frequently than control mutations (marked with
an asterisk, and reproduced in Figure 2 of the main text).
(TIF)
Figure S3 Frequencies of mutated residues across all proteins (A,
B); in ordered regions (C, D), and in disordered regions (E, F). In
panel (A) frequencies of amino acids across whole proteins were
normalized by frequencies in human proteins from UniProt; (C)
frequencies in ORs normalized with frequencies from PDBS25
(sequences of proteins with solved crystal structures from PBD,
filtered at 25% pairwise sequence identity); and (E) frequencies in
IDR with frequencies in experimentally confirmed disordered
regions from the DisProt database, as described in (Vacic et al.,
2007).
(TIF)
Figure S4 Frequencies of residues mutated into (A, B) across all
proteins, (C, D) in ordered regions and in (E, F) disordered regions
only. Normalization was performed as in Figure S3 and (Vacic
et al., 2007).
(TIF)
Figure S5 Frequencies of mutations from (A,B) and into (C,D)
arginine in DM, Poly and NES mutation datasets. (A) and (C) were
normalized by the frequencies of amino acids from human
proteins in UniProt, as described in (Vacic et al., 2007).
(TIF)
Figure S6 Histogram of PolyPhen-2 scores for (A) disease
mutations shows drop in sensitivity for mutations in IDRs and
specifically for DRD mutations, while scores for (B) neutral
polymorphisms and (C) neutral evolutionary substitutions show a
drop in specificity for DRO mutations. High scores indicate
deleterious mutations.
(TIF)
Figure S7 Histogram of SIFT scores for (A) disease mutations
shows drop in sensitivity for mutations in IDRs and specifically for
DRD mutations, while scores for (B) neutral polymorphisms and
(C) neutral evolutionary substitutions show a drop in specificity for
DRO mutations. Scores#0.05 indicate damaging mutations.
(TIF)
Figure S8 Scatter plots of the number of mutations per protein
against the rank of the protein for (A) DM, (B) Poly and (C) NES.
Disease mutation (DM) plot (A) identifies four proteins which have
an unusually high number of annotated disease mutations: tumor
suppressor p53 (P04637), coagulation factor VIII (P00451),
androgen receptor (P10275), and Stargardt disease protein
(P78363). Taken together, these 4 proteins account for a total of
12.4% of all disease mutations, and were removed from subsequent
analysis. The protein with most mutations in plot (B) is titin
(Q8WZ42), the longest protein in the human proteome as annotated
in UniProt, which has been removed from the Poly dataset.
(TIF)
Table S1 Disease mutations have higher frequencies in ordered
regions independently of the choice of predictor (VLXT, VSL3B,
and IUPred).
(XLS)
Table S2 Comparison of mutation rates in amino acid
substitutions per residue (mean 6 standard deviation) in
disordered (IDR) and ordered (OR) regions in three studied
datasets, disease mutations (DM), polymorphisms (Poly) and
neutral evolutionary substitutions (NES). P-values were computed
using Students t test.
(XLS)
Table S3 Disorder-to-order transition mutations are significant-
ly enriched in DM independently of the choice of predictor.
Order-to-disorder transition mutations are significantly depleted in
disease when compared to NES but not when compared to Poly
(after multiple testing correction). P-values were computed using
Fisher’s exact test.
(XLS)
Table S4 PHD secondary structure predictions (E strand, H
helix, L loop) for disease mutations (DM), polymorphisms (Poly)
and neutral evolutionary substitutions (NES) show an enrichment
of predicted helices (H) and strands (E) in DM, and a
corresponding depletion of loops (L).
(XLS)
Table S5 Changes in PHD secondary structure predictions (E
strand, H helix, L loop) upon mutations in disease mutations
(DM), polymorphisms (Poly) and neutral evolutionary substitutions
(NES) dataset.
(XLS)
Table S6 Number of mutations in disease (DM), polymorphisms
(Poly) and neutral substitutions (NES) datasets mapped to human
instances of the eukaryotic linear motifs (ELM). Compared to
controls, IDR disease mutations are enriched in ELM regions.
DRO mutations in DM are significantly enriched in ELM regions
compared to NES.
(XLS)
Table S7 Fold difference for Swiss Prot FT Level 1 features
between DM and Poly (first two rows), and DM and NES (last
three rows) for DRO and ORD transitions. Only features with
Bonferroni-corrected P-values,0.05 in either DRO or ORD
were included.
(XLS)
Table S8 Fold difference for Swiss Prot FT Level 2 features
between DM and Poly (first five rows), and DM and NES (the
remaining rows) for DRO and ORD transitions. Since no
features in DM/Poly and only two features in DM/NES passed
the Bonferroni-corrected P-value cutoff, all features with uncor-
rected P-value,0.01 in either DRO or ORD were included.
Features in bold have significantly different fold difference
between disease mutations in DRO or ORD.
(XLS)
Table S9 PolyPhen-2 and SIFT calls for all mutations in DM,
Poly and NES show a drop in sensitivity for calling disease-
associated mutations in IDRs (bold font in row DM IDR) and a
drop in specificity for DRO (bold font in rows Poly DRO and
NES DRO).
(XLS)
Table S10 670 disease mutations from UniProt predicted to
result in a DRO transition.
(XLS)
Table S11 590 disease mutations from UniProt predicted to
result in a ORD transition.
(XLS)
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Table S12 Summary of the AMD simulations as secondary
structure propensities in DNA-binding domain of tumor protein
p63 in the wild-type p63 (Before mutation) and in the R243W
mutant (After mutation). ‘‘Difference’’ displays the differences
between the wildtype and the R243W mutant and demonstrates
than upon the mutation propensity towards a-helical conforma-
tion increases leading to a decrease in entropy of the sampled
populations for all but one residue (K242). Abbreviations are as
follows: b, b-sheet (2180,w,2100, y.120); ppII, poly-proline II
(2100,w,0, y.120); a, a-helix (2100,w,0, 275,y,225);
Frust. a, ‘‘frustrated’’ a-helix (2159,w,2100, 275,y,225);
Entropy, Shannon’s entropy of the residue propensities.
(XLS)
Text S1 Details of a-MoRF predictions.
(DOC)
Text S2 Details of accelerated molecular dynamics (AMD)
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